315 related articles for article (PubMed ID: 28962904)
21. Saturated Fatty Acid Analogues of Cell-Penetrating Peptide PepFect14: Role of Fatty Acid Modification in Complexation and Delivery of Splice-Correcting Oligonucleotides.
Lehto T; Vasconcelos L; Margus H; Figueroa R; Pooga M; Hällbrink M; Langel Ü
Bioconjug Chem; 2017 Mar; 28(3):782-792. PubMed ID: 28209057
[TBL] [Abstract][Full Text] [Related]
22. Hydrophobic and electrostatic interactions between cell penetrating peptides and plasmid DNA are important for stable non-covalent complexation and intracellular delivery.
Upadhya A; Sangave PC
J Pept Sci; 2016 Oct; 22(10):647-659. PubMed ID: 27723187
[TBL] [Abstract][Full Text] [Related]
23. Fluorescence imaging with single-molecule sensitivity and fluorescence correlation spectroscopy of cell-penetrating neuropeptides.
Vukojević V; Gräslund A; Bakalkin G
Methods Mol Biol; 2011; 789():147-70. PubMed ID: 21922406
[TBL] [Abstract][Full Text] [Related]
24. Insight into the cellular uptake mechanism of a secondary amphipathic cell-penetrating peptide for siRNA delivery.
Konate K; Crombez L; Deshayes S; Decaffmeyer M; Thomas A; Brasseur R; Aldrian G; Heitz F; Divita G
Biochemistry; 2010 Apr; 49(16):3393-402. PubMed ID: 20302329
[TBL] [Abstract][Full Text] [Related]
25. Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells.
Nakase I; Tanaka G; Futaki S
Mol Biosyst; 2013 May; 9(5):855-61. PubMed ID: 23306408
[TBL] [Abstract][Full Text] [Related]
26. Fluorescent Leakage Assay to Investigate Membrane Destabilization by Cell-Penetrating Peptide.
Konate K; Seisel Q; Vivès E; Boisguérin P; Deshayes S
J Vis Exp; 2020 Dec; (166):. PubMed ID: 33393518
[TBL] [Abstract][Full Text] [Related]
27. Modification of a designed amphipathic cell-penetrating peptide and its effect on solubility, secondary structure, and uptake efficiency.
Jafari M; Karunaratne DN; Sweeting CM; Chen P
Biochemistry; 2013 May; 52(20):3428-35. PubMed ID: 23614788
[TBL] [Abstract][Full Text] [Related]
28. An Amphipathic Structure of a Dipropylglycine-Containing Helical Peptide with Sufficient Length Enables Safe and Effective Intracellular siRNA Delivery.
Oba M; Shibuya M; Yamaberi Y; Yokoo H; Uchida S; Ueda A; Tanaka M
Chem Pharm Bull (Tokyo); 2023; 71(3):250-256. PubMed ID: 36858531
[TBL] [Abstract][Full Text] [Related]
29. Thermodynamics of cell penetrating peptides on lipid membranes: sequence and membrane acidity regulate surface binding.
Ramírez PG; Del Pópolo MG; Vila JA; Longo GS
Phys Chem Chem Phys; 2020 Oct; 22(40):23399-23410. PubMed ID: 33048078
[TBL] [Abstract][Full Text] [Related]
30. Insights into membrane translocation of the cell-penetrating peptide pVEC from molecular dynamics calculations.
Alaybeyoglu B; Sariyar Akbulut B; Ozkirimli E
J Biomol Struct Dyn; 2016 Nov; 34(11):2387-98. PubMed ID: 26569019
[TBL] [Abstract][Full Text] [Related]
31. Optimisation of vectorisation property: A comparative study for a secondary amphipathic peptide.
Konate K; Lindberg MF; Vaissiere A; Jourdan C; Aldrian G; Margeat E; Deshayes S; Boisguerin P
Int J Pharm; 2016 Jul; 509(1-2):71-84. PubMed ID: 27224007
[TBL] [Abstract][Full Text] [Related]
32. Glycosaminoglycans are required for translocation of amphipathic cell-penetrating peptides across membranes.
Pae J; Liivamägi L; Lubenets D; Arukuusk P; Langel Ü; Pooga M
Biochim Biophys Acta; 2016 Aug; 1858(8):1860-7. PubMed ID: 27117133
[TBL] [Abstract][Full Text] [Related]
33. Modeling of non-covalent complexes of the cell-penetrating peptide CADY and its siRNA cargo.
Crowet JM; Lins L; Deshayes S; Divita G; Morris M; Brasseur R; Thomas A
Biochim Biophys Acta; 2013 Feb; 1828(2):499-509. PubMed ID: 23000699
[TBL] [Abstract][Full Text] [Related]
34. Membrane interacting peptides: from killers to helpers.
Dufourc EJ; Buchoux S; Toupé J; Sani MA; Jean-François F; Khemtémourian L; Grélard A; Loudet-Courrèges C; Laguerre M; Elezgaray J; Desbat B; Odaert B
Curr Protein Pept Sci; 2012 Nov; 13(7):620-31. PubMed ID: 23116443
[TBL] [Abstract][Full Text] [Related]
35. Internalization of nucleoside phosphates into live cells by complex formation with different CPPs and JBS-nucleoducin.
Mussbach F; Pietrucha R; Schaefer B; Reissmann S
Methods Mol Biol; 2011; 683():375-89. PubMed ID: 21053144
[TBL] [Abstract][Full Text] [Related]
36. In Vitro Assays: Friends or Foes of Cell-Penetrating Peptides.
Liu J; Afshar S
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630650
[TBL] [Abstract][Full Text] [Related]
37. Cholesterol re-organisation and lipid de-packing by arginine-rich cell penetrating peptides: Role in membrane translocation.
Almeida C; Maniti O; Di Pisa M; Swiecicki JM; Ayala-Sanmartin J
PLoS One; 2019; 14(1):e0210985. PubMed ID: 30673771
[TBL] [Abstract][Full Text] [Related]
38. Electrostatic effects in saturation of membrane binding of cationic cell-penetrating peptide.
Svirina A; Terterov I
Eur Biophys J; 2021 Jan; 50(1):15-23. PubMed ID: 33245398
[TBL] [Abstract][Full Text] [Related]
39. Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and their stability in simulated gastric conditions.
Ezzat K; Zaghloul EM; El Andaloussi S; Lehto T; El-Sayed R; Magdy T; Smith CI; Langel U
J Control Release; 2012 Aug; 162(1):1-8. PubMed ID: 22698942
[TBL] [Abstract][Full Text] [Related]
40. Impact of Peptide Sequence on Functional siRNA Delivery and Gene Knockdown with Cyclic Amphipathic Peptide Delivery Agents.
Jagrosse ML; Baliga UK; Jones CW; Russell JJ; García CI; Najar RA; Rahman A; Dean DA; Nilsson BL
Mol Pharm; 2023 Dec; 20(12):6090-6103. PubMed ID: 37963105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
